Purinergic receptors and metabolic function

Drug Development Research

Volumn 39, Issue 3-4, 1996, Pages 413-425

  Petit, P ^a   Loubatieres Mariani M M ^a   Keppens, S ^b   Sheehan, M J ^c  

^a Faculté de Médecine   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adipocyte; Hepatocyte; Pancreatic A cell; Pancreatic B cell; Purinceptors

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; GLYCEROL; INSULIN; PURINE RECEPTOR; RECEPTOR SUBTYPE;

ADIPOCYTE; CONFERENCE PAPER; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOGENOLYSIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; LIVER; NONHUMAN; PANCREAS ISLET; SKELETAL MUSCLE;

EID: 0030437882     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<413::AID-DDR23>3.0.CO;2-0     Document Type: Conference Paper

References (67)

1. 2y purinoceptors? Pharm Ther 64:445-475.
2. Ader M, Bergman RN (1996): Evidence that "autoregulation" of hepatic glucose output is mediated by free fatty acids. Abstr Annu Meet Am Diabet Assoc 1996:902.
3. 1 agonist DPCPX is a potent prolipolytic agent in the rat isolated adipocyte. Br J Pharmacol 108:183P.
4. Bertrand G, Chapal J, Loubatières-Mariani MM (1986): Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion. Am J Physiol 251:E416-E421.
5. 2-purinoceptors on β cell and pancreatic vascular bed. Br J Pharmacol 102:783-787.
6. Bertrand G, Gross R, Chapal J, Loubatières-Mariani MM (1989): Difference in the potentiating effect of adenosine triphosphate and α,β-methylene ATP on the biphasic insulin response to glucose. Br J Pharmacol 98:998-1004.
7. 2 purinoceptors mediating insulin secretion from perfused rat pancreas. Br J Pharmacol 102:627-630.
8. Bouscarel B, Meurer K, Decker C, Exton JH (1988): The role of protein kinase C in the inactivation of hepatic glycogen synthase by calcium-mobilising agonists. Biochem J 251:47-53.
9. 6-phenylisopropyladenosine on rat islet function and metabolism. Biochem J 204:689-696.
10. Castan C, Valet P, Quideau N, Voisin T, Ambid L, Laburthe M, Lafontan M, Carpene C (1994): Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammalian adipocytes. Am J Physiol 266: R1141-R1147.
11. Ghapal J, Loubatières-Mariani MM (1981): Effects of phosphate-modi-fied adenine nucleotide analogues on insulin secretion from perfused rat pancreas. Br J Pharmacol 73:105-110.
12. Chapal J, Louhatières-Mariani MM, Roye R, Zerbib A (1984): Effects of adenosine, adenosine triphosphate and structural analogues on glucagon secretion from the perfused pancreas of rat in vitro. Br J Pharmacol 83:927-933.
13. 2-subtype adenosine receptor on pancreatic glucagon secreting cells. Br J Pharmacol 86:563-569.
14. Coates J, Sheehan MJ, Strong P (1994): 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): A useful tool for pharmacologists and physiologists? Gen Pharmacol 25:387-394.
15. Coppack SW, Jensen MD, Miles JM (1994): In vivo regulation of lipolysis in humans. J Lipid Res 35:177-193.
16. Craik KM, McLennan AG, Fisher MJ (1993): Adenine dinucleotide-mediated activation of glycogen phosphorylase in isolated liver cells. Cell Signal 5:89-96.
17. 2+-mobilizing purinoceptors on rat hepatocytes. Biochem J 269:499-502.
18. 4A) to rat liver cell membranes. 314:687-693.
19. Fain JN, Pointer RH, Ward WF (1972): Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation and lipolysis in fat cells. J Biol Chem 247:6866-6872.
20. Firsov D, Asrab L, Mandon D, Sizume-Perez S, De-Reuffignac C, Chabardef D (1995): Arachidonic acid inhibits hormone-stimulated cAMP accumulation in the medullary thick ascending limb of the rat kidney by a mechanism sensitive to pertussis toxin. Physiol Arch 429:636-646.
21. Frayn KN (1993): Insulin resistance and lipid metabolism. Curr Opin Lipidol 4:197-204.
22. Frayn KN, Williams CM, Arner P (1996): Are increased plasma nonesterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 90:243-253.
23. Fredholm BB (1995): Adenosine, adenosine receptors and the action of caffeine. Pharmacol Toxicol 76:93-101.
24. 3-tetraphosphate in single rat hepatocytes are indistinguishable from those induced by ADP and ATP respectively. Biochem J 310:629-635.
25. 2-Adrenergic potentiation of adenosine-stimulating effect on glucagon secretion. Endocrinology 121:765-769.
26. Gross R, Bertrand G, Ribes G, Petit P, Loubatières-Mariani MM (1987b): Epinephrine potentiates adenosine-stimulating effect on glucagon secretion. Am J Physiol 252:E426-E430.
27. Hellmer J, Marcus G, Sonnenfeld T, Arner P (1992): Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 75:15-20.
28. Heseltine L, Webster JM, Taylor R (1995): Adenosine effects upon insulin: action on lipolysis and glucose transport in human adipocytes. Mol Cell Biochem 144:147-151.
29. 1 subtype adenosine receptor on pancreatic insulin-secreting cells. Eur J Pharmacol 136:109-112.
30. 2Y purinoceptor responses of β cells and vascular bed are preserved in diabetic rat pancreas. Br J Pharmacol 106:610-615.
31. 2y, purinoceptor agonist, adenosine-5′-O-(2-thiodiphosphate). Br J Pharmacol 109:183-187.
32. Hillaire-Buys D, Chapal J, Bertrand G, Petit P, Loubatières-Mariani MM (1994): Purinergic receptors on insulin-secreting cells. Fundam Clin Pharmacol 8:117-127.
33. Hunnicutt JW, Hardy RW, Williford J, McDonald JM (1994): Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes 43:540-545.
34. Irving HR, Exton JH (1987): Phosphatidylcholine breakdown in rat liver plasma membranes. J Biol Chem 262:3440-3443.
35. Junco M, Diaz-Gnerra MJM, Bosca L (1993): Differential calcium mobilisation by vasopressin, angiotensin H, gastrin-releasing peptide, and adenosine triphosphate in adult and fetal hepatocytes: Relevance for the activation of calcium dependent enzymes. Endocrinology 132:309-318.
36. Kashiwagi A (1995): Rationale and hurdles of inhibitors of hepatic gluconeogenesis in treatment of diabetes mellitus. Diabetes Res Clin Pract 28 (Suppl):S195-S200.
37. 3 receptors exist? Gen Pharmacol 23:303-307.
38. Keppens S (1993): The complex interaction of ATP and UTP with isolated hepatocytes. How many receptors? (ion Pharmacol 24:283-289.
39. Keppens S (1996): Effects of diadenosine-triphosphate and diadenosine-tetraphosphate on rat liver cells: Differences and similarities with ADP and ATP Biochem Pharmacol 52:441-445.
40. Keppens S, De Wulf H (1991): Characterisation of the biological effects of 2-methylthio-ATP on rat hepatocytes: Clear-cut differences with ATP Br J Pharmacol 104:301-304.
41. 2-purinergic agonists increase cytosolic calcium but not inositol 1,4,5-trisphosphate in isolated rat hepatocytes. Biochim Biophys Acta 1269:316-322.
42. Keppens S, Vandekerckhove A, De Wulf H (1992): Extracellular ATP and UTP exert similar effects on rat isolated hepatocytes. Br J Pharmacol 150:475-479.
43. Keppens S, Vandekerckhove A, De Wulf H (1993): Characterisation of the effects of adenosine 5′-β(-thio)-diphosphate in rat liver. Br J Pharmacol 108:663-668.
44. Lamarine RJ (1994): Selected health and behavioral effects related to the use of caffeine. J Community Health 19:449-466.
45. 1 adenosine receptors in the human fat cell: Tissue distribution and regulation of radioligand binding. Eur J Pharmacol 206:139-147.
46. 2 adrenoceptor. Eur J Pharmacol 267:225-232.
47. Loudos C, Cooper DMF, Schlegel W, Rodbell M (1978): Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: Basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc Natl Acad Sci USA 75:5362-5366.
48. Loubatières-Mariani MM, Loubatières A, Chapal J, Valette G (1976): Adenosine triphosphate (ATP) et glucose. Action sur les sécrétions d'insuline et de glucagon. CR Soc Biol 170:833-836.
49. Loubatières-Mariani MM, Chapal J, Lignon F, Valette G (1979): Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol 59:277-286.
50. Louhatières-Mariani MM, Chapal J (1988): Purinergic receptors involved in the stimulation of insulin and glucagon secretion. Diabete Metab 14:119-126.
51. Loubatières-Mariani MM, Petit P, Chapal J, Hillaire-Buys D, Bertrand G, Ribes G (1995): Effects of purinoceptor agonists on insulin secretion. In Bellardinelli L, Pelleg A (eds): Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Boston: Kluwer Academic, pp 337-345.
52. Malcolm KC, Trammel SE, Exton JH (1995): Purinergic agonists and G protein stimulation of phospholipase D in rat liver plasma membranes: Independence from phospholipase G activation. Biochim Biophys Acta 1268:152-158.
53. Marcus C, Margery V Kamel A, Brönnegård M (1994): Effects of growth hormone on lipolysis in humans. Acta Paedriatr Suppl 406:54-58.
54. 2purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and production of inositol trisphosphate in rat hepatocytes. J Biol Chem 262:13483-90.
55. Qu X, Donnelly R (1996): Metabolic and hemodynamic effects of a new adenosine (A1) receptor agonist, GR79236, in normal and fructose-fed rats. Abstr Annu Meet Am Diabet Assoc 1996:605.
56. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963): The glucose-fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789.
57. Reaven GM (1993): Role of insulin resistance in the pathophysiology of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 9(Suppl 1):5S-12S.
58. Rebrin K, Steil G, Getty L, Bergman RN (1995): Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045.
59. 1-type adenosine receptors in rat white and brown adipocytes. Biochem J 269:157-161.
60. Saloranta G, Groop L (1996): Interactions between glucose and FFA metabolism in man. Diabetes Metab Rev 12:15-36.
61. Thompson GS, Strong P, Mikhailidis DP (1994): Improvement of ketoacidosis in the diabetic rat after administration of the oral antilipolytic agent GR79236. Clin Sci 86:593-598.
62. Thompson GS, Strong P, Mikhailidis DP (1996): Triacylglycerol lowering properties of the adenosine analog GR 79236 during 5 days of dosing large, old rats: A pilot study. Nutrition Research 16:1925-1932.
63. 2 purinoceptors by suramin in rat hepatocytes. Eur J Pharmacol 226:363-1365.
64. Townsend-Nicholson A, Shine J (1992): Molecular cloning and characterisation of a human brain A1 adenosine receptor cDNA. Mol Brain Res 16:365-370.
65. 35S] adenosine 5′-β-(2-thiodiphosphate) and intracellular calcium responses in rat liver parenchymal cells. Biochem Pharmacol 45:801-807.
66. Venkatakrishnan G, Exton JH (1996): Identification and determinants in the α-subunit of Gq required for phospholipase G activation. J Biol Chem 271:5066-5072.
67. 2+ channel by activation of G, proteins. J Biol Chem 271:11737-744.